An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2015
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary) ; Measles vaccines; Meningococcal vaccine conjugate; Yellow fever vaccine
- Indications Rotavirus infections
- Focus Pharmacodynamics
- 19 Aug 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 31 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 30 Dec 2014 Planned End Date changed from 1 Mar 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.